Beyond Type 1 Advocacy


We Believe

Everyone impacted by diabetes—type 1, type 2 and beyond—has a right to the best care possible for their unique situation. This means having access to the technology, medications, support, and clinical care teams that help each individual manage their chronic condition. We work to increase access and remove barriers, giving our community the tools needed to succeed.

High quality, modern insulin must be available to people with diabetes regardless of employment or insurance status, across all demographics, without barriers and at an affordable and predictable price point.

Our advocacy work focuses on equity: making sure people with diabetes have access to care by tackling issues like systemic racism, financial privilege and discrimination in all its forms.

Federal Actions

If Congress doesn’t hear about what matters to our community, they won’t take action. Sending messages to your elected representatives is one of many ways to raise your voice on important issues impacting people with diabetes. The latest actions available are listed below, but keep checking back, as new bills are introduced often.

What you can do right now: fill out your name and street address and click next. Our grassroots platform will find your elected representatives and walk you through sending a message to let them know your thoughts!

State Actions

States have power over our health through budgets and bills, so it’s just as important to let our state representatives know how their decisions can impact our daily diabetes management.

State insulin price capping bills have been one way to provide financial relief to some members of our community. However, these bills only assist those who have select state-regulated commercial insurance. To learn more about the limitations of insulin capping bills, click here.

We are actively monitoring these state insulin price capping bills (listed below), as we believe that even helping a few community members with out-of-pocket costs is one step closer to ensuring all people with diabetes in the United Sates have affordable access to insulin. If you’re interested in learning more about a particular bill and where it stands in the state’s legislature process, click on the name of the bill.

Letters + Coalitions

Beyond Type 1 has weighed in on the latest policy measures through sign-on letters and public comments:

Beyond Type 1 is an active member of the following advocacy coalitions:


A program of Beyond Type 1, connecting people with diabetes who take insulin to assistance programs and low-cost solutions that match their unique situation. MORE
drug rebates

Drug Rebates, Insulin and Affording Life with Diabetes in the United States

The issues surrounding drug rebates in the U.S. highlight the need for reform, especially when it comes to insulin and living with diabetes.MORE

The United States’ Insulin Crisis

Whether you need insulin right now or want to lend your voice to the fight for affordable, consistent access to insulin in the US, start here.MORE

How Insulin Pricing Works in the U.S.

The American healthcare system has created a complex web of players who exchange money for pharmaceutical products in ways that are not entirely clear.MORE

Coverage 2 Control

Join the Coverage 2 Control campaign from JDRF, and tell insurance companies to provide affordability, choice and coverage to help people with type 1 diabetes (T1D) better control the disease.MORE


insulin copays

The Affordable Insulin Now Act: A Step Toward Federal Legislation

The Affordable Insulin Now Act, if passed in its current form, could help bring down the cost of insulin for millions of insured people with diabetes.MORE

The Potential Impact of Build Back Better on American Healthcare

Dive into the basics of Build Back Better, why people with diabetes should follow the bill as it progresses, and the impact it could have on your health.MORE

Inside the Senate Report on Rising Insulin Prices

A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.MORE

Get the Facts on Insulin Pricing + The Presidential Transition

A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin. MORE


Another Reminder that Racial/Ethnic Inequality Exists in Diabetes Care

Despite the variety of diabetes medications and technology, race and ethnicity still weigh heavily on a person’s access to these life-saving tools.MORE
drug rebates

Drug Rebates, Insulin and Affording Life with Diabetes in the United States

The issues surrounding drug rebates in the U.S. highlight the need for reform, especially when it comes to insulin and living with diabetes.MORE

WRITTEN BY BT1 Editorial Team, POSTED 02/18/21, UPDATED 03/30/23

This piece was authored collaboratively by the Beyond Type 1 Editorial Team.